integMET
Home
About
Documentation
Diff Profiles
Metabolites
studies
Gragh
Metabolites
›
INLNBZTYRLXXCU-YTBMDRSFSA-N
1-(9Z,12Z-heptadecadienoyl)-2-(7Z,10Z,13Z,16Z-docosatetraenoyl)-glycero-3-phospho-(1'-myo-inositol)
INLNBZTYRLXXCU-YTBMDRSFSA-N
CHEBI:138561
0 Reactome links
1 studies
1
Observed studies
1
Observed diff profiles
0
Reactome pathways
Metabolite details
Identifier
INLNBZTYRLXXCU-YTBMDRSFSA-N
InChI Key
INLNBZTYRLXXCU-YTBMDRSFSA-N
IUPAC name
Preferred name
1-(9Z,12Z-heptadecadienoyl)-2-(7Z,10Z,13Z,16Z-docosatetraenoyl)-glycero-3-phospho-(1'-myo-inositol)
INN name
—
Synonym
PI(17:2(9Z,12Z)/22:4(7Z,10Z,13Z,16Z))
ChEBI
CHEBI:138561
Reactome pathways
No Reactome pathways listed for this metabolite.
Observed in studies
Metabolomics and lipidomics reveal perturbation of sphingolipid metabolism by a novel anti-trypanosomal 3-(oxazolo[4,5-b]pyridine-2-yl)anilide
Observed in differential profiles
Control_vs_OXPA_Treatment